tradingkey.logo


tradingkey.logo


SelectQuote Inc

SLQT
0.614USD
+0.020+3.35%
āļ›āļīāļ” 03/30, 16:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
99.29MāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
5.65P/E TTM


āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ SelectQuote Inc āļšāļĢāļīāļĐāļąāļ—

SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises the SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expense, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy.

āļ‚āđ‰āļ­āļĄāļđāļĨ SelectQuote Inc


āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™SLQT
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—SelectQuote Inc
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļMay 21, 2020
āļ‹āļĩāļ­āļĩāđ‚āļ­Danker (Timothy Robert)
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™1181
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“May 21
āļ—āļĩāđˆāļ­āļĒāļđāđˆ6800 West 115Th Street
āđ€āļĄāļ·āļ­āļ‡OVERLAND PARK
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ OMX NASDAQ Basic NYSE
āļ›āļĢāļ°āđ€āļ—āļĻUnited States of America
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ66211
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ19132741994
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://ir.selectquote.com/investor-home/default.aspx
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™SLQT
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļMay 21, 2020
āļ‹āļĩāļ­āļĩāđ‚āļ­Danker (Timothy Robert)

āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—āļ‚āļ­āļ‡ SelectQuote Inc


āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Robert Clay (Bob) Grant
Mr. Robert Clay (Bob) Grant
President
President
4.32M
--
Mr. Timothy Robert (Tim) Danker
Mr. Timothy Robert (Tim) Danker
Chief Executive Officer, Director
Chief Executive Officer, Director
2.63M
--
Ms. Denise L. Devine, CPA
Ms. Denise L. Devine, CPA
Independent Director
Independent Director
371.21K
+14.18%
Dr. Kavita K. Patel, M.D.
Dr. Kavita K. Patel, M.D.
Independent Director
Independent Director
363.21K
+14.49%
Mr. Ryan Moore Clement
Mr. Ryan Moore Clement
Chief Financial Officer
Chief Financial Officer
322.39K
+1.26%
Ms. Sarah Anderson
Ms. Sarah Anderson
Executive Vice President - Pharmacy Services
Executive Vice President - Pharmacy Services
51.63K
+85.44%
Mr. Srdjan Vukovic
Mr. Srdjan Vukovic
Independent Director
Independent Director
9.50K
--
Mr. Donald L. Hawks, III
Mr. Donald L. Hawks, III
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Earl H. (Trace) Devanny, III
Mr. Earl H. (Trace) Devanny, III
Independent Director
Independent Director
--
--
Mr. Raymond F. Weldon
Mr. Raymond F. Weldon
Independent Director
Independent Director
--
--
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Robert Clay (Bob) Grant
Mr. Robert Clay (Bob) Grant
President
President
4.32M
--
Mr. Timothy Robert (Tim) Danker
Mr. Timothy Robert (Tim) Danker
Chief Executive Officer, Director
Chief Executive Officer, Director
2.63M
--
Ms. Denise L. Devine, CPA
Ms. Denise L. Devine, CPA
Independent Director
Independent Director
371.21K
+14.18%
Dr. Kavita K. Patel, M.D.
Dr. Kavita K. Patel, M.D.
Independent Director
Independent Director
363.21K
+14.49%
Mr. Ryan Moore Clement
Mr. Ryan Moore Clement
Chief Financial Officer
Chief Financial Officer
322.39K
+1.26%
Ms. Sarah Anderson
Ms. Sarah Anderson
Executive Vice President - Pharmacy Services
Executive Vice President - Pharmacy Services
51.63K
+85.44%

āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰

āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Pharmacy revenue
218.54M
66.46%
Commission
94.97M
28.88%
Production bonus and other revenue
15.30M
4.65%
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„USD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
United States
328.81M
100.00%
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Pharmacy revenue
218.54M
66.46%
Commission
94.97M
28.88%
Production bonus and other revenue
15.30M
4.65%

āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™

āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 21 āļ.āļž.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 21 āļ.āļž.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Brookside Equity Partners LLC
10.03%
BlackRock Institutional Trust Company, N.A.
5.21%
The Vanguard Group, Inc.
4.59%
Abrams Bison Investments, L.L.C.
4.49%
Mariner Wealth Advisors
3.61%
āļ­āļ·āđˆāļ™ āđ†
72.08%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Brookside Equity Partners LLC
10.03%
BlackRock Institutional Trust Company, N.A.
5.21%
The Vanguard Group, Inc.
4.59%
Abrams Bison Investments, L.L.C.
4.49%
Mariner Wealth Advisors
3.61%
āļ­āļ·āđˆāļ™ āđ†
72.08%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
20.01%
Individual Investor
11.45%
Investment Advisor/Hedge Fund
10.51%
Private Equity
10.03%
Hedge Fund
8.31%
Research Firm
2.14%
Corporation
0.62%
Bank and Trust
0.26%
Pension Fund
0.11%
āļ­āļ·āđˆāļ™ āđ†
36.57%

āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 1 āļĄ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 1 āļĄ.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q4
334
93.93M
53.29%
-7.59M
2025Q3
327
94.38M
53.63%
-3.32M
2025Q2
332
110.44M
63.96%
+4.81M

āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™


āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
Brookside Equity Partners LLC
17.68M
10.05%
--
--
Sep 20, 2025
BlackRock Institutional Trust Company, N.A.
9.01M
5.12%
-200.07K
-2.17%
Sep 30, 2025
The Vanguard Group, Inc.
8.19M
4.65%
-20.74K
-0.25%
Sep 30, 2025
Abrams Bison Investments, L.L.C.
7.91M
4.5%
--
--
Sep 30, 2025
Mariner Wealth Advisors
6.37M
3.62%
+3.06K
+0.05%
Sep 30, 2025
Grant (William Thomas II)
4.66M
2.65%
+94.89K
+2.08%
Nov 12, 2024
Grant (Robert Clay)
4.32M
2.45%
--
--
Sep 20, 2025
Grant (William Thomas III)
4.20M
2.39%
--
--
Sep 20, 2025
Geode Capital Management, L.L.C.
3.33M
1.89%
+29.89K
+0.91%
Sep 30, 2025
State Street Investment Management (US)
2.96M
1.68%
-139.64K
-4.50%
Sep 30, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 2 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 2 āļ˜.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
iShares Micro-Cap ETF
0.06%
Fidelity Enhanced Small Cap ETF
0.04%
WisdomTree US SmallCap Quality Growth Fund
0.04%
Avantis US Small Cap Equity ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
Avantis US Small Cap Value ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
iShares Micro-Cap ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.06%
Fidelity Enhanced Small Cap ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.04%
WisdomTree US SmallCap Quality Growth Fund
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.04%
Avantis US Small Cap Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.02%
Invesco RAFI US 1500 Small-Mid ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.02%
ProShares Hedge Replication ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.01%
iShares Russell 2000 ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.01%
Avantis US Small Cap Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.01%
Schwab U.S. Small-Cap ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.01%

āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ


āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 0.00 USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ

āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™


āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™